Hydroxychloroquine

The antimalaria drug hydroxychloroquine has generated significant controversy. A new study suggests that if it is given early, it can reduce mortality in people with severe COVID-19. But our expert points out weaknesses in the study’s design.Amid an ongoing search for an effective COVID-19 treatment, the debate about the antimalaria drug hydroxychloroquine (HCQ) continues. There…

(CNN)Prescriptions for the anti-malarial drugs chloroquine and hydroxychloroquine skyrocketed in the US from February to March, a time when the drugs, though unproven, were touted as treatments for t…

GENEVA (Reuters) - The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with COVID-19 after they failed to reduce mortality. The setback came as the WHO also reported more than 200,000 new cases globally of the disease…

FILE - In this April 6, 2020 file photo, a pharmacist holds a bottle of the drug hydroxychloroquine in Oakland, Calif. Results published Wednesday, June 3, 2020, by the New England Journal of Medicine show that hydroxychloroquine was no better than placebo pills at preventing illness from the COVID-19 coronavirus. The drug did not seem…

Researchers at the Henry Ford Health System in Southeast Michigan have found that early administration of the drug hydroxychloroquine makes hospitalized patients substantially less likely to die.The study, published in the International Journal of Infectious Diseases, determined that hydroxychloroquine provided a "66% hazard ratio reduction," and hydroxychloroquine and azithromycin a 71 percent reduction, compared to neither treatment.In-hospital mortality was…